1-(5-Bromo-6-chloro-4-(trifluoromethyl)pyridin-2-yl)piperazine, 95.0%, 1g

4-Bromo-DL-phenylalanine>98.0%(HPLC)(T)1g

4-Bromophenyl benzyl ether, 98.0%, 1g

(1S)-1-(2-Chloro-4-fluorophenyl)ethan-1-amine hydrochloride, 95%, 1g

Di(N-succinimidyl) 3,3'-Dithiodipropionate [Cross-linking Reagent]>97.0%(N)5g

tert-Butyl 2'-(((trifluoromethyl)sulfonyl)oxy)-5',6'-dihydrospiro[pyrrolidine-3,4'-pyrrolo[1,2-b]pyrazole]-1-carboxylate, 98%, 1g

Esmolol>98.0%(GC)100mg

4-Hydroxy-2-(4-trifluoromethyl-phenyl)-thiazole-5-carboxylic acidethylester, 1g

(1S,3S)-(3-Hydroxymethyl-cyclohexyl)-carbamic acid tert-butyl ester, 98%, 5g

Ethyl 2-(trifluoromethyl)-1,8-naphthyridine-3-carboxylate, 95+%, 1g

Bis[4,4'-dimethoxy(dithiobenzil)]nickel(II)>98.0%(HPLC)5g

4,5-Difluoroindole, 95.0%, 5g

N-(Hydroxymethyl)acrylamide>98.0%(T)25g